Skip to main content
Premium Trial:

Request an Annual Quote

David Gorin, Robert Sprung

Premium
This week the Canary Foundation and American Cancer Society Early Detection Postdoctoral Fellowship Program for 2008 gave five recipients $138,000 each over three years to support research into early cancer detection.
 
Among the recipients are David Gorin at Harvard University, who is developing a new assay for the comparative analysis of protease activities in diseased and healthy tissues by “simultaneously investigating the activity of proteases on thousands of substrate peptides,” the Canary Foundation said in a statement.
 
Robert Sprung at the Vanderbilt-Ingram Cancer Center also was named a fellow. He is developing, standardizing, and applying a method for the proteomic analysis of formalin-fixed paraffin-embedded colon adema tissue.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.